Janusz Wojciechowski, European Commissioner for Agriculture from Poland, and David Clarinval, Belgian Minister of Agriculture at the AGRI Council in November 2023 © UE

After the EU Parliament’s Agriculture (AGRI) Committee called for a patent ban on NGT-1 breeds on 8 January, the ENVI Committee will give its input to the EU Commissions draft law on new genomic techniques.

AMsilk GmbH's headquarters in Neuried. The company, in which Novo holds a €29m equity stake,  has no manufacturing facility but works with contractors such as 21st.BIO. © AMSilk GmbH

AMSilk GmbH and Danish 21st.BIO A/S announce partnership to accelerate the production of advanced materials made from spider silk-based proteins.

Ruben de Francisco, Founder & CEO Onera Health. © Onera Health NV

Sleep diagnostics specialist Onera Health NV has closed a €30m (US$32m) Series C financing round co-led by EQT Life Sciences and Gimv.

Basilea headquarters in Alschil, Switzerland. © Mohamd Ghani - wikipedia.org

Macrocycle library secialist Spexis AG is set to sell a preclinical antibiotics programme afor CHF2m to Basilea Pharmaceutica Ltd.

© Enifer

Microbial production specialist Enifer has secured a €12m grant from Business Finland to build a mycoprotein ingredient factory with a capacity of 300,000 tonnes annually.

Mogu Panels are made from soft, foam-like mycelium materials and of upcycled textile residues. © Mogu Srl

Italian mycelium specialist Mogu Srl has closed a €11m Series A financing co-led by CDP Venture Capital and the  European Circular Bioeconomy Fund (ECBF VC)

Antibiotic resistance tests; the bacteria in the culture on the left are sensitive to the antibiotics contained in the white paper discs. The bacteria on the right are resistant to most of the antibiotics. © Dr Graham Beards  wikipedia.org

Novo Nordisk Foundation has partnered with CARB-X investing US$25m to help SMEs to fight drug-resistant infections.

© Jabri & Abadie Nat.Rev.Immunol 2015; Waldmann et al. J. Exp. Med 2019; Created with BioRender

Calypso Biotech BV has entered into an agreement to be acquired by Novartis AG, which will pay. Calypso’s US$250m upfront upon closing plus of up to US$175.

FDA Building 31 houses the Office of the Commissioner and the Office of Regulatory Affairs. © U.S. Food and Drug Administration

Following in the footsteps of the European Medicines Agency (EMA), the US FDA is now also investigating the side effects of obesity blockbusters.

Boehringer Ingelheim headquarters. © Boehringer Ingelheim

Boehringer Intelheim is expanding its antfibrotics pipeline licencing a first-in-class treatment for fibro-inflammatory diseases from  Kyowa Kirin Co. Ltd.